176 related articles for article (PubMed ID: 23043184)
1. Interactions between CYP2E1 and CYP2B4: effects on affinity for NADPH-cytochrome P450 reductase and substrate metabolism.
Kenaan C; Shea EV; Lin HL; Zhang H; Pratt-Hyatt MJ; Hollenberg PF
Drug Metab Dispos; 2013 Jan; 41(1):101-10. PubMed ID: 23043184
[TBL] [Abstract][Full Text] [Related]
2. Heteromeric complex formation between CYP2E1 and CYP1A2: evidence for the involvement of electrostatic interactions.
Kelley RW; Cheng D; Backes WL
Biochemistry; 2006 Dec; 45(51):15807-16. PubMed ID: 17176103
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome b5 increases the rate of product formation by cytochrome P450 2B4 and competes with cytochrome P450 reductase for a binding site on cytochrome P450 2B4.
Zhang H; Im SC; Waskell L
J Biol Chem; 2007 Oct; 282(41):29766-76. PubMed ID: 17693640
[TBL] [Abstract][Full Text] [Related]
4. Effects of ionic strength on the functional interactions between CYP2B4 and CYP1A2.
Kelley RW; Reed JR; Backes WL
Biochemistry; 2005 Feb; 44(7):2632-41. PubMed ID: 15709776
[TBL] [Abstract][Full Text] [Related]
5. Interactions between cytochromes P450 2B4 (CYP2B4) and 1A2 (CYP1A2) lead to alterations in toluene disposition and P450 uncoupling.
Reed JR; Cawley GF; Backes WL
Biochemistry; 2013 Jun; 52(23):4003-13. PubMed ID: 23675771
[TBL] [Abstract][Full Text] [Related]
6. Uncovering the role of hydrophobic residues in cytochrome P450-cytochrome P450 reductase interactions.
Kenaan C; Zhang H; Shea EV; Hollenberg PF
Biochemistry; 2011 May; 50(19):3957-67. PubMed ID: 21462923
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Interactions Among CYP1A2, CYP2B4, and NADPH-cytochrome P450 Reductase: Identification of Specific Protein Complexes.
Connick JP; Reed JR; Backes WL
Drug Metab Dispos; 2018 Mar; 46(3):197-203. PubMed ID: 29233819
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 system proteins reside in different regions of the endoplasmic reticulum.
Park JW; Reed JR; Brignac-Huber LM; Backes WL
Biochem J; 2014 Dec; 464(2):241-9. PubMed ID: 25236845
[TBL] [Abstract][Full Text] [Related]
9. Evidence supporting the interaction of CYP2B4 and CYP1A2 in microsomal preparations.
Cawley GF; Zhang S; Kelley RW; Backes WL
Drug Metab Dispos; 2001 Dec; 29(12):1529-34. PubMed ID: 11717170
[TBL] [Abstract][Full Text] [Related]
10. Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.
Tan Y; Patten CJ; Smith T; Yang CS
Arch Biochem Biophys; 1997 Jun; 342(1):82-91. PubMed ID: 9185616
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of diabetes on CYP2E1 and CYP2B4 proteins and associated drug metabolizing enzyme activities in rabbit liver.
Arinç E; Arslan S; Adali O
Arch Toxicol; 2005 Aug; 79(8):427-33. PubMed ID: 15906000
[TBL] [Abstract][Full Text] [Related]
12. Polymorphic variants of cytochrome P450 2B6 (CYP2B6.4-CYP2B6.9) exhibit altered rates of metabolism for bupropion and efavirenz: a charge-reversal mutation in the K139E variant (CYP2B6.8) impairs formation of a functional cytochrome p450-reductase complex.
Zhang H; Sridar C; Kenaan C; Amunugama H; Ballou DP; Hollenberg PF
J Pharmacol Exp Ther; 2011 Sep; 338(3):803-9. PubMed ID: 21659470
[TBL] [Abstract][Full Text] [Related]
13. The binding affinity of carcinogenic N-nitrosodimethylamine and N-nitrosomethylaniline to cytochromes P450 2B4, 2E1 and 3A6 does not dictate the rate of their enzymatic N-demethylation.
Sulc M; Hodek P; Stiborová M
Gen Physiol Biophys; 2010 Jun; 29(2):175-85. PubMed ID: 20577029
[TBL] [Abstract][Full Text] [Related]
14. Functional interactions between cytochromes P450 1A2 and 2B4 require both enzymes to reside in the same phospholipid vesicle: evidence for physical complex formation.
Reed JR; Eyer M; Backes WL
J Biol Chem; 2010 Mar; 285(12):8942-52. PubMed ID: 20071338
[TBL] [Abstract][Full Text] [Related]
15. Amphipol-facilitated elucidation of the functional tetrameric complex of full-length cytochrome P450 CYP2B4 and NADPH-cytochrome P450 oxidoreductase.
Cheng S; Bo Z; Hollenberg P; Osawa Y; Zhang H
J Biol Chem; 2021; 296():100645. PubMed ID: 33839156
[TBL] [Abstract][Full Text] [Related]
16. Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5.
Kaspera R; Naraharisetti SB; Evangelista EA; Marciante KD; Psaty BM; Totah RA
Biochem Pharmacol; 2011 Sep; 82(6):681-91. PubMed ID: 21726541
[TBL] [Abstract][Full Text] [Related]
17. Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase.
Zhukov A; Ingelman-Sundberg M
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):453-8. PubMed ID: 10333489
[TBL] [Abstract][Full Text] [Related]
18. Effects of diabetes on rabbit kidney and lung CYP2E1 and CYP2B4 expression and drug metabolism and potentiation of carcinogenic activity of N-nitrosodimethylamine in kidney and lung.
Arinç E; Arslan S; Bozcaarmutlu A; Adali O
Food Chem Toxicol; 2007 Jan; 45(1):107-18. PubMed ID: 17034923
[TBL] [Abstract][Full Text] [Related]
19. Global analysis of protein-protein interactions reveals multiple CYP2E1-reductase complexes.
Jamakhandi AP; Kuzmic P; Sanders DE; Miller GP
Biochemistry; 2007 Sep; 46(35):10192-201. PubMed ID: 17685587
[TBL] [Abstract][Full Text] [Related]
20. CYP2D6-CYP2C9 protein-protein interactions and isoform-selective effects on substrate binding and catalysis.
Subramanian M; Low M; Locuson CW; Tracy TS
Drug Metab Dispos; 2009 Aug; 37(8):1682-9. PubMed ID: 19448135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
